Total Payments
$2,612
2024 Payments
$942.40
Companies
25
Transactions
143
Medicare Patients
4,632
Medicare Billing
$664,366
Payment Breakdown by Category
Food & Beverage$2,453 (93.9%)
Education$158.37 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,453 | 134 | 93.9% |
| Education | $158.37 | 9 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $388.46 | 24 | $0 (2024) |
| Travere Therapeutics, Inc. | $355.80 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $344.41 | 20 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $230.64 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $183.83 | 11 | $0 (2024) |
| Amgen Inc. | $175.16 | 9 | $0 (2024) |
| Vifor Pharma, Inc. | $159.62 | 10 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $141.21 | 7 | $0 (2024) |
| Abbott Laboratories | $91.19 | 4 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $78.96 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $942.40 | 51 | Travere Therapeutics, Inc. ($315.52) |
| 2023 | $627.30 | 34 | Mallinckrodt Hospital Products Inc. ($95.78) |
| 2022 | $561.00 | 32 | Novo Nordisk Inc ($168.38) |
| 2021 | $211.62 | 13 | Otsuka America Pharmaceutical, Inc. ($57.42) |
| 2020 | $43.00 | 2 | GlaxoSmithKline, LLC. ($30.26) |
| 2019 | $79.17 | 2 | BAXTER HEALTHCARE ($66.28) |
| 2018 | $12.96 | 1 | Novo Nordisk Inc ($12.96) |
| 2017 | $134.07 | 8 | AstraZeneca Pharmaceuticals LP ($36.93) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: CRITICAL CARE | ||||||
| 12/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.31 | General |
| 12/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.26 | General |
| 12/10/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $1.03 | General |
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEPHROLOGY | ||||||
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $2.10 | General |
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Bone Health | ||||||
| 09/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $37.99 | General |
| 09/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.73 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEPHROLOGY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Endocrinology | ||||||
| 07/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 07/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $0.39 | General |
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,247 | 2,051 | $479,144 | $141,478 |
| 2022 | 18 | 1,345 | 2,393 | $576,166 | $171,960 |
| 2021 | 18 | 1,209 | 2,097 | $505,560 | $177,141 |
| 2020 | 15 | 831 | 1,709 | $477,102 | $173,787 |
Total Patients
4,632
Total Services
8,250
Medicare Billing
$664,366
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 224 | 617 | $161,109 | $53,163 | 33.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 26 | 122 | $115,656 | $33,057 | 28.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 29 | 91 | $70,980 | $20,195 | 28.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 58 | 83 | $18,675 | $5,967 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $20,800 | $5,808 | 27.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 16 | 36 | $21,024 | $5,526 | 26.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 664 | 815 | $24,450 | $4,824 | 19.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 37 | $12,062 | $3,636 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 42 | $7,224 | $2,581 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 42 | $7,436 | $2,237 | 30.1% |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | Office | 2023 | 20 | 49 | $6,305 | $1,565 | 24.8% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2023 | 19 | 22 | $6,540 | $1,424 | 21.8% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2023 | 16 | 25 | $5,578 | $1,347 | 24.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,304 | $148.40 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 666 | $174,264 | $54,975 | 31.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 33 | 155 | $146,940 | $44,302 | 30.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 32 | 115 | $89,700 | $26,793 | 29.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 15 | 37 | $21,608 | $6,048 | 28.0% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2022 | 29 | 94 | $21,017 | $5,529 | 26.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 683 | 883 | $26,490 | $5,237 | 19.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 35 | 68 | $15,300 | $5,231 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $17,332 | $5,078 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 86 | $15,224 | $4,885 | 32.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 31 | 35 | $11,410 | $3,702 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 44 | $7,568 | $2,491 | 32.9% |
About Dr. Hassan Honainy, MD
Dr. Hassan Honainy, MD is a Nephrology healthcare provider based in Low Moor, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932104023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hassan Honainy, MD has received a total of $2,612 in payments from pharmaceutical and medical device companies, with $942.40 received in 2024. These payments were reported across 143 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,453).
As a Medicare-enrolled provider, Honainy has provided services to 4,632 Medicare beneficiaries, totaling 8,250 services with total Medicare billing of $664,366. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Low Moor, VA
- Active Since 06/16/2005
- Last Updated 03/20/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1932104023
Products in Payments
- JYNARQUE (Drug) $230.64
- Kerendia (Drug) $183.83
- FARXIGA (Drug) $171.62
- Veltassa (Drug) $149.79
- EVENITY (Biological) $130.09
- ACTHAR (Biological) $125.52
- Wegovy (Drug) $110.52
- Rybelsus (Drug) $93.07
- LOKELMA (Drug) $91.85
- FREESTYLE LIBRE 3 (Device) $91.19
- Ozempic (Drug) $80.28
- TARPEYO (Drug) $78.96
- JARDIANCE (Drug) $67.99
- RAYALDEE (Drug) $66.52
- Renal - HomeChoice Automated PD (Device) $66.28
- TRELEGY ELLIPTA (Drug) $48.62
- RYBELSUS (Drug) $39.79
- Saxenda (Drug) $39.40
- SYMBICORT (Drug) $36.93
- ULTOMIRIS (Biological) $34.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.